Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
Recent news and posts
New version of the NABM nomenclature released in France
The NABM Nomenclature serves as the primary and permanent reimbursement catalog for in-vitro diagnostic tests covered under statutory health insurance in France.
On May 27, 2025, a new version of the Nomenclature of Medical Biology Procedures (NABM 97) was released. One new code was introduced: 9011 “Pre-analytical patient care package in the event of COVID screening” (coefficient B-17).
The B value is €0.25 for metropolitan France.
Other changes include modifying the descriptions and wording of several existing codes.
See the details in French here (NABM) and here (Order on NABM v.97 changes)
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.